Literature DB >> 26998685

High circulating oestrone and low testosterone correlate with adverse clinical outcomes in men with advanced liver disease.

Marie Sinclair1,2, Paul J Gow3,4, Peter W Angus3,4, Rudolf Hoermann4, David J Handelsman5, Gary Wittert6, Sean Martin6, Mathis Grossmann4,7.   

Abstract

BACKGROUND & AIMS: Circulating testosterone is usually reduced in men with cirrhosis, but there has not been a comprehensive analysis of androgen status or circulating oestrogens. Little is known about associations between circulating sex steroids with aspects of health in this population.
METHODS: We report data from men with cirrhosis and low serum testosterone (<12 nmol/L or calculated free testosterone <230 pmol/L). Comprehensive circulating sex steroid profiles were measured by liquid chromatography-mass spectrometry and compared with age-matched controls. Relationships between sex hormone levels, severity of liver disease, biochemistry and clinical outcomes were assessed.
RESULTS: Serum oestrone and oestradiol were significantly elevated in men with cirrhosis compared with controls (median, 869.1 pmol/L vs. 133.8 pmol/L and 166.7 pmol/L vs. 84.6 pmol/L respectively). Serum oestrone correlated with MELD score (correlation +0.306, P < 0.001) and inversely correlated with serum sodium (correlation -0.208, P = 0.004) and haemoglobin (correlation -0.177, P = 0.012). No such correlations were observed for oestradiol. Serum testosterone levels inversely correlated with MELD score (correlation -0.294, P < 0.001) and positively with handgrip strength (correlation +0.242, P < 0.001), physical activity (correlation +0.276, P = 0.012), haemoglobin (correlation +0.282, P < 0.001) and serum sodium (+0.344, P < 0.001). Dihydrotestosterone inversely correlated with MELD score (correlation -0.225, P = 0.002) and shared similar significant relationships to testosterone.
CONCLUSION: Low serum androgens and elevated serum oestrone (but not oestradiol) are associated with higher MELD and individual adverse health outcomes in cirrhotic cohort of men selected for low testosterone. Serum oestrone may be a novel marker of ill health in this population. Whether low androgens are markers or mediators of ill health requires further investigation.
© 2016 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  cirrhosis; oestradiol; oestrone; testosterone

Mesh:

Substances:

Year:  2016        PMID: 26998685     DOI: 10.1111/liv.13122

Source DB:  PubMed          Journal:  Liver Int        ISSN: 1478-3223            Impact factor:   5.828


  6 in total

Review 1.  Radiation therapy for primary breast lymphoma in male gynecomastia: a rare case report and review of the literature.

Authors:  Naoya Ishibashi; Masaharu Hata; Takao Mochizuki; Kogi Ogawa; Hiroaki Sugiura; Yoshinori Takekawa; Toshiya Maebayashi; Takuya Aizawa; Masakuni Sakaguchi; Osamu Abe
Journal:  Int J Hematol       Date:  2016-05-25       Impact factor: 2.490

2.  Imbalanced expression pattern of steroid receptor coactivator-1 and -3 in liver cancer compared with normal liver: An immunohistochemical study with tissue microarray.

Authors:  Shan Li; Huiyan Zhang; Yanlan Yu; Mengying Liu; Deyu Guo; Xuqing Zhang; Jiqiang Zhang
Journal:  Oncol Lett       Date:  2018-09-17       Impact factor: 2.967

3.  Lower testosterone levels predict increasing severity and worse outcomes of hepatitis B virus-related acute-on-chronic liver failure in males.

Authors:  Yandi Huang; Dong Yan; Huafen Zhang; Bin Lou; Ren Yan; Yifan Yao; Minya Dong; Donglei Yang; Feifei Lv; Yu Chen
Journal:  BMC Gastroenterol       Date:  2021-12-06       Impact factor: 3.067

4.  The Loss of Masculine With Declined Serum DHT Is Associated With High Risk of Hepatocellular Carcinoma in Chinese Men.

Authors:  Lichun Wang; Azhar Rasul; Zili Liu; Ying Pan; Weihua Wang; Jiang Li; Xiaomeng Li
Journal:  Front Endocrinol (Lausanne)       Date:  2020-06-30       Impact factor: 5.555

5.  Assessing men with erectile dysfunction before and after living donor liver transplantation in real-world practice: Integrating laboratories into clinical settings.

Authors:  Heng-Chieh Chiang; You-Chiuan Chien; Ping-Yi Lin; Hsiu-Ling Lee; Yao-Li Chen
Journal:  PLoS One       Date:  2018-11-20       Impact factor: 3.240

6.  The pituitary tumour-transforming gene 1/delta-like homologue 1 pathway plays a key role in liver fibrogenesis.

Authors:  Meritxell Perramón; Silvia Carvajal; Vedrana Reichenbach; Guillermo Fernández-Varo; Loreto Boix; Laura Macias-Muñoz; Pedro Melgar-Lesmes; Jordi Bruix; Shlomo Melmed; Santiago Lamas; Wladimiro Jiménez
Journal:  Liver Int       Date:  2022-01-30       Impact factor: 8.754

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.